Gustavo Dziewczapolski, Scientific DirectorJul 24 minResearch Update: LAMA2We are honored to support groundbreaking discoveries related to LAMA2-Related Dystrophy.
Lani Knutson, Advocacy Team LeaderJul 12 minCure CMD Seeks Advocacy Advisory Council MembersJoin a newly forming council to help direct legislative priorities for the CMD community.
Kassidy C.Jun 273 minYouth Advocate Attends First Virtual Hill DayI had the opportunity to kick off my rare advocacy journey and experience my first Capitol Hill Day.
Gustavo Dziewczapolski, Scientific DirectorJun 62 miniMM Joins the MAGIC Consortium to Advance Research on Muscular DystrophiesThe MAGIC research team welcomes iMM to the consortium to add a cellular perspective to muscle-on-chip technologies
Rachel AlvarezJun 52 minOmigapil Publication Now AvailableLong-awaited publication about the Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy now published.
Gustavo Dziewczapolski, Scientific DirectorMay 294 minResearch Update: SELENONWe are honored to support groundbreaking discoveries related to SELENON-Related Disorders.
Giulia Da ReMay 2318 minInterview with Gustavo Dziewczapolski: Doctor in Neuropharmacology and Scientific Director of Cure CMDExplore an in-depth interview with Gustavo Dziewczapolski, Doctor in Neuropharmacology and Scientific Director of Cure CMD. Gain insights in
Gustavo Dziewczapolski, Scientific DirectorMay 12 min2024 Myology Congress RecapCure CMD’s Scientific Director, Dr. Gustavo Dziewczapolski, provides a recap of his attendance at the 8th International Myology Congress in